Quarterly report pursuant to Section 13 or 15(d)

Stock-based Expense - Narrative (Details)

v3.19.3
Stock-based Expense - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2019
Jul. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based expense $ 0.4 $ 1.1  
Hipercept      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Contingent consideration (up to)     $ 28.0
Hipercept | Performance-Based Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation cost $ 0.8 $ 0.8  
Stock Grants | Simple Bills | Performance-Based Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Contingent consideration (up to)     10.0
Stock Grants | Hipercept | Performance-Based Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Contingent consideration (up to)     $ 2.7